MolDX: Molecular Diagnostic Tests (MDT)
J15 · Effective Oct 1, 2015
11 active Medicare policies list 0539U, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Feb 16, 2017
J8 · Effective Feb 16, 2017
National · Effective Jul 1, 2026
National · Effective Jul 1, 2026
3 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 0539U |
|---|---|---|
| Genetic Liquid Biopsy in the Management of Cancer and Cancer Surveillance | Aug 22, 2026 | Covered |
| Genetic Liquid Biopsy in the Management of Cancer and Cancer Surveillance | Jun 14, 2026 | Covered |
| Policy | Effective | Status of 0539U |
|---|---|---|
| Circulating Tumor DNA and Circulating Tumor Cells for Management (Liquid Biopsy) of Solid Tumor Cancers |
National · Effective Jul 1, 2026
J5 · Effective Jul 1, 2026
| Jul 1, 2026 |
| Covered |